FDA Approved: CABERGOLINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for cabergoline filed by Mylan Pharmaceuticals Inc., resulting in a revised label and potential expansion of use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperprolactinemia
• Parkinson Disease

Drugs mentioned

• CABERGOLINE (CABERGOLINE)

Snippet

SUPPL AP for CABERGOLINE (CABERGOLINE)